1. Home
  2. BNZI vs DOMH Comparison

BNZI vs DOMH Comparison

Compare BNZI & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • DOMH
  • Stock Information
  • Founded
  • BNZI 2016
  • DOMH 1967
  • Country
  • BNZI United States
  • DOMH United States
  • Employees
  • BNZI N/A
  • DOMH N/A
  • Industry
  • BNZI
  • DOMH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNZI
  • DOMH Health Care
  • Exchange
  • BNZI Nasdaq
  • DOMH Nasdaq
  • Market Cap
  • BNZI 8.9M
  • DOMH 8.8M
  • IPO Year
  • BNZI N/A
  • DOMH N/A
  • Fundamental
  • Price
  • BNZI $1.64
  • DOMH $11.94
  • Analyst Decision
  • BNZI Strong Buy
  • DOMH
  • Analyst Count
  • BNZI 1
  • DOMH 0
  • Target Price
  • BNZI $125.00
  • DOMH N/A
  • AVG Volume (30 Days)
  • BNZI 4.7M
  • DOMH 4.0M
  • Earning Date
  • BNZI 02-28-2025
  • DOMH 03-31-2025
  • Dividend Yield
  • BNZI N/A
  • DOMH N/A
  • EPS Growth
  • BNZI N/A
  • DOMH N/A
  • EPS
  • BNZI N/A
  • DOMH N/A
  • Revenue
  • BNZI $4,310,782.00
  • DOMH $12,589,000.00
  • Revenue This Year
  • BNZI $5.58
  • DOMH N/A
  • Revenue Next Year
  • BNZI $58.87
  • DOMH N/A
  • P/E Ratio
  • BNZI N/A
  • DOMH N/A
  • Revenue Growth
  • BNZI N/A
  • DOMH 1117.50
  • 52 Week Low
  • BNZI $1.21
  • DOMH $0.83
  • 52 Week High
  • BNZI $67.65
  • DOMH $13.58
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 50.20
  • DOMH 82.78
  • Support Level
  • BNZI $1.51
  • DOMH $6.31
  • Resistance Level
  • BNZI $1.74
  • DOMH $13.58
  • Average True Range (ATR)
  • BNZI 0.26
  • DOMH 1.72
  • MACD
  • BNZI -0.00
  • DOMH 1.00
  • Stochastic Oscillator
  • BNZI 27.40
  • DOMH 86.16

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.

Share on Social Networks: